🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and immunogenicity of B...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-07-27
Trial ID
NCT03621670
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0159)
Start Date
2019-06-19
Trial ID
NCT03893448
Treatments Being Tested
This study is undertaken to generate clinical data on GSK Biologicals' comb...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-03
Trial ID
NCT00892775
By doing this study, it is the hope to learn whether an injection of the me...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08
Trial ID
NCT07539155
Treatments Being Tested
Participants will receive vaccination for measles, mumps, and rubella (MMR)...
Status
Completed
Location
Zambia Emory HIV Research Project
Start Date
2015-08
Trial ID
NCT02589678
Treatments Being Tested
Eligible participants were randomly assigned (1:1:1), using block randomiza...
Status
Unknown
Location
Shanghai Municipal Center for Disease Control and Prevention
Start Date
2023-08
Trial ID
NCT05952505
Primary Objective: 1. To describe the vaccine seroprotection (antibody tit...
Status
Completed
Location
Investigational Site Number :4840001
Start Date
2018-10-17
Trial ID
NCT03630705
Treatments Being Tested
Warts can be resistant to treatment or return despite the use of many thera...
Status
Completed
Location
Zagazig university
Start Date
2020-11-20
Trial ID
NCT05254561
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of a...
Status
Completed
Location
Hansa Sanatorium GmbH
Start Date
2016-08-17
Trial ID
NCT02861586
Treatments Being Tested
This study evaluates the immunogenicity and consistency of 3 Hib-MenCY-TT v...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-02-22
Trial ID
NCT00289783